Intercure Ltd (INCR)

$1.51 -0.04 (-2.58%)
Market Cap 70.64M
Revenue (ttm) 66.28M
Net Income (ttm) -18.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.64%
Debt to Equity Ratio 0.29
Volume 9,200
Avg Vol 10,368
Day's Range N/A - N/A
Shares Out 45.57M
Stochastic %K 67%
Beta 1.22
Analysts Strong Buy
Price Target $7.00

Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 7 746 05012
Fax: 972 9 768 0244
Address:
85 Medinat ha-Yehudim Street, Herzliya, Israel
Rage_Against_The_Machine
Rage_Against_The_Machine May. 1 at 8:01 PM
$INCR reports a strong start to 2025 with Q1 revenue expected to grow over 25% to NIS 70M and positive Adjusted EBITDA. Expansion into Germany and the UK with Cookies™, plus NIS 66M in funding, signals aggressive growth. Compensation for war-related damages (NIS 82M received) adds financial stability. Bullish on the execution here. https://www.prnewswire.com/news-releases/intercure-announces-fy2024-results-and-provides-q1-2025-update--revenue-of-nis-239-million-and-adjusted-ebitda-of-nis-24-million--strong-start-to-2025-302444433.html
0 · Reply
futurewilltell
futurewilltell Apr. 30 at 6:30 PM
$INCR https://www.marijuanamoment.net/trumps-pick-to-lead-dea-says-marijuana-rescheduling-review-will-be-one-of-my-first-priorities-in-the-job/
0 · Reply
realaxelrod
realaxelrod Apr. 25 at 7:05 PM
$INCR It's coming https://www.pymnts.com/news/banking/2025/report-trump-seeks-reintroduction-of-cannabis-banking-bill/
0 · Reply
PenkeTrading
PenkeTrading Apr. 2 at 4:02 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of INC Research Holdings Inc. Is that bullish or bearish? $INCR #RsiOversold #NASDAQ
0 · Reply
BullRunner13
BullRunner13 Mar. 10 at 4:45 PM
$GTBIF TCNNF Here is one not to many know about! I bought them a whole back! Sitting pretty with plenty of cash flow! I'm sure when the military stops fighting it's going to take off! Do your DD. I believe this is a diamond in the rough! Seems to be under the radar! $INCR $CURLF $CRLBF $SNDL
2 · Reply
BullRunner13
BullRunner13 Mar. 10 at 4:37 PM
$GTBIF CURLF $CRLBF $SNDL $INCR https://www.newyorkfed.org/newsevents/news/research/2025/20250310
0 · Reply
JesusWhale
JesusWhale Jan. 16 at 10:04 PM
$INCR cup and handle on the daily just waiting to takeoff! Gaza ceasefire should send this in the near term.
0 · Reply
D1gitalN0mad
D1gitalN0mad Jan. 4 at 6:20 PM
$INCR $4-$5 stock minimum keep stacking, just a matter of time.
0 · Reply
futurewilltell
futurewilltell Jan. 3 at 7:47 PM
$INCR
0 · Reply
Stonkerbonker
Stonkerbonker Dec. 23 at 9:17 PM
$INCR will we see 2 soon? I hope so
1 · Reply
Latest News on INCR
InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

May 1, 2025, 4:00 PM EDT - 7 weeks ago

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

Feb 12, 2025, 6:35 PM EST - 4 months ago

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

Dec 20, 2024, 8:32 AM EST - 6 months ago

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

Sep 14, 2024, 2:32 PM EDT - 10 months ago

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

Aug 29, 2024, 6:03 PM EDT - 10 months ago

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

Aug 28, 2024, 8:54 AM EDT - 10 months ago

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

InterCure: A Cannabis Industry Leader Still Flying Under The Radar

Jun 30, 2024, 3:42 AM EDT - 1 year ago

InterCure: A Cannabis Industry Leader Still Flying Under The Radar

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference

May 22, 2024, 6:45 AM EDT - 1 year ago

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

May 1, 2024, 8:27 AM EDT - 1 year ago

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

InterCure: Bargain Israel Cannabis Play

Apr 22, 2024, 3:41 PM EDT - 1 year ago

InterCure: Bargain Israel Cannabis Play

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

Apr 1, 2024, 9:09 AM EDT - 1 year ago

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

Mar 22, 2024, 11:58 AM EDT - 1 year ago

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

Feb 23, 2024, 12:12 PM EST - 1 year ago

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

InterCure Provides an Update Regarding Nir Oz Facility

Feb 13, 2024, 4:46 PM EST - 1 year ago

InterCure Provides an Update Regarding Nir Oz Facility

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

Jan 31, 2024, 9:27 AM EST - 1 year ago

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

InterCure Wins Cannolam Arbitration Proceeding

Oct 31, 2023, 4:39 PM EDT - 1 year ago

InterCure Wins Cannolam Arbitration Proceeding

InterCure Provides an Update Regarding the Security Situation in Israel

Oct 17, 2023, 5:04 PM EDT - 1 year ago

InterCure Provides an Update Regarding the Security Situation in Israel

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Aug 31, 2023, 7:45 PM EDT - 1 year ago

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

InterCure: Leader In Israel's Growing Medical Cannabis Market

Aug 2, 2023, 7:22 PM EDT - 2 years ago

InterCure: Leader In Israel's Growing Medical Cannabis Market

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

Jul 10, 2023, 5:00 PM EDT - 2 years ago

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

Jun 9, 2023, 5:18 PM EDT - 2 years ago

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

May 15, 2023, 5:59 PM EDT - 2 years ago

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

May 15, 2023, 5:45 PM EDT - 2 years ago

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

Apr 25, 2023, 7:19 PM EDT - 2 years ago

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

Apr 20, 2023, 8:30 AM EDT - 2 years ago

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

InterCure: How Bright Is The Company's Future In 2023

Apr 6, 2023, 10:24 AM EDT - 2 years ago

InterCure: How Bright Is The Company's Future In 2023

InterCure Ltd. (INCR) Q4 2022 Earnings Call Transcript

Apr 4, 2023, 6:56 PM EDT - 2 years ago

InterCure Ltd. (INCR) Q4 2022 Earnings Call Transcript

InterCure Reschedules 2022 Full Year Results Conference Call

Apr 3, 2023, 3:27 PM EDT - 2 years ago

InterCure Reschedules 2022 Full Year Results Conference Call

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

Mar 31, 2023, 8:00 PM EDT - 2 years ago

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

Feb 14, 2023, 8:30 AM EST - 2 years ago

InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

Feb 1, 2023, 8:30 AM EST - 2 years ago

InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

InterCure: Why The Company Is Grossly Undervalued By Wall Street

Jan 20, 2023, 12:22 PM EST - 2 years ago

InterCure: Why The Company Is Grossly Undervalued By Wall Street

Cannabis Is A Long-Term Play (Podcast Transcript)

Jan 9, 2023, 6:30 AM EST - 2 years ago

Cannabis Is A Long-Term Play (Podcast Transcript)

Cannabis REITs: Smoked Out

Dec 29, 2022, 11:15 AM EST - 2 years ago

Cannabis REITs: Smoked Out

ACB AFCG BYND CARA CGC CNBS CRON

InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

Dec 19, 2022, 8:30 AM EST - 2 years ago

InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

InterCure to Participate in Cowen 5th Annual Cannabis Conference

Dec 8, 2022, 9:30 AM EST - 2 years ago

InterCure to Participate in Cowen 5th Annual Cannabis Conference

Update regarding Better Transaction

Nov 23, 2022, 4:30 PM EST - 2 years ago

Update regarding Better Transaction

Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Nov 17, 2022, 8:17 AM EST - 2 years ago

Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Nov 17, 2022, 8:00 AM EST - 2 years ago

Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

OGI

CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Nov 15, 2022, 11:18 AM EST - 2 years ago

CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Nov 15, 2022, 9:03 AM EST - 2 years ago

InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY

Nov 11, 2022, 8:32 AM EST - 2 years ago

InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY

Buy InterCure To Ride The Coming Wave Of Global Cannabis Growth

Nov 8, 2022, 11:42 PM EST - 2 years ago

Buy InterCure To Ride The Coming Wave Of Global Cannabis Growth

InterCure: Highlighting A Profitable Israeli Cannabis Operator

Oct 25, 2022, 12:11 PM EDT - 2 years ago

InterCure: Highlighting A Profitable Israeli Cannabis Operator

Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

Sep 16, 2022, 4:30 PM EDT - 3 years ago

Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

InterCure: A Leader In Global Cannabis

Sep 6, 2022, 5:25 PM EDT - 3 years ago

InterCure: A Leader In Global Cannabis

InterCure Ltd (INCR) CEO Alexander Rabinovitch on Q2 2022 Results - Earnings Call Transcript

Aug 16, 2022, 2:11 PM EDT - 3 years ago

InterCure Ltd (INCR) CEO Alexander Rabinovitch on Q2 2022 Results - Earnings Call Transcript

InterCure Reports Record Breaking Second Quarter Financial Results

Aug 15, 2022, 9:15 AM EDT - 3 years ago

InterCure Reports Record Breaking Second Quarter Financial Results

InterCure to Release its Q2 2022 Results and Hold a Conference Call

Aug 11, 2022, 10:30 AM EDT - 3 years ago

InterCure to Release its Q2 2022 Results and Hold a Conference Call

InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth

Jul 21, 2022, 9:00 AM EDT - 3 years ago

InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth

Rage_Against_The_Machine
Rage_Against_The_Machine May. 1 at 8:01 PM
$INCR reports a strong start to 2025 with Q1 revenue expected to grow over 25% to NIS 70M and positive Adjusted EBITDA. Expansion into Germany and the UK with Cookies™, plus NIS 66M in funding, signals aggressive growth. Compensation for war-related damages (NIS 82M received) adds financial stability. Bullish on the execution here. https://www.prnewswire.com/news-releases/intercure-announces-fy2024-results-and-provides-q1-2025-update--revenue-of-nis-239-million-and-adjusted-ebitda-of-nis-24-million--strong-start-to-2025-302444433.html
0 · Reply
futurewilltell
futurewilltell Apr. 30 at 6:30 PM
$INCR https://www.marijuanamoment.net/trumps-pick-to-lead-dea-says-marijuana-rescheduling-review-will-be-one-of-my-first-priorities-in-the-job/
0 · Reply
realaxelrod
realaxelrod Apr. 25 at 7:05 PM
$INCR It's coming https://www.pymnts.com/news/banking/2025/report-trump-seeks-reintroduction-of-cannabis-banking-bill/
0 · Reply
PenkeTrading
PenkeTrading Apr. 2 at 4:02 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of INC Research Holdings Inc. Is that bullish or bearish? $INCR #RsiOversold #NASDAQ
0 · Reply
BullRunner13
BullRunner13 Mar. 10 at 4:45 PM
$GTBIF TCNNF Here is one not to many know about! I bought them a whole back! Sitting pretty with plenty of cash flow! I'm sure when the military stops fighting it's going to take off! Do your DD. I believe this is a diamond in the rough! Seems to be under the radar! $INCR $CURLF $CRLBF $SNDL
2 · Reply
BullRunner13
BullRunner13 Mar. 10 at 4:37 PM
$GTBIF CURLF $CRLBF $SNDL $INCR https://www.newyorkfed.org/newsevents/news/research/2025/20250310
0 · Reply
JesusWhale
JesusWhale Jan. 16 at 10:04 PM
$INCR cup and handle on the daily just waiting to takeoff! Gaza ceasefire should send this in the near term.
0 · Reply
D1gitalN0mad
D1gitalN0mad Jan. 4 at 6:20 PM
$INCR $4-$5 stock minimum keep stacking, just a matter of time.
0 · Reply
futurewilltell
futurewilltell Jan. 3 at 7:47 PM
$INCR
0 · Reply
Stonkerbonker
Stonkerbonker Dec. 23 at 9:17 PM
$INCR will we see 2 soon? I hope so
1 · Reply
NoStyle79
NoStyle79 Dec. 20 at 1:50 PM
$INCR could move to 1.70+ on the news
0 · Reply
First_Class_Seaman
First_Class_Seaman Dec. 7 at 8:56 PM
$ENTO about to blast through 1 $INCR WW
0 · Reply
futurewilltell
futurewilltell Dec. 4 at 3:57 PM
$INCR it looks great 👍
0 · Reply
JohnKeynes
JohnKeynes Nov. 15 at 7:31 PM
$INCR Just started buying. Will save bullets for later though. Black Friday prices unless there is something not in broader knowledge.
2 · Reply
JesusWhale
JesusWhale Nov. 14 at 11:03 PM
$INCR 30% down in two weeks time. Off of what? The fundamentals have not changed. Revenue is set to double in the second half of 2024, easy buy/accumulate at these levels and hold for 200%+ gains.
1 · Reply
JohnKeynes
JohnKeynes Nov. 13 at 8:11 PM
$INCR 1.20 and lower. Fill me.
0 · Reply
JohnKeynes
JohnKeynes Nov. 12 at 4:45 PM
$INCR Closely watching now, ready to reload. At least +200% expected if the plan is on track.
1 · Reply
JesusWhale
JesusWhale Nov. 6 at 2:44 PM
$INCR really sucks that this sells off when there’s negative momentum in the sector, but doesn’t pump when there’s overall posture sentiment in the sector. With Trump winning, the US is further and further away from federally legalizing marijuana. But Intercure doesn’t even have operations in the US, nor do they sell in the US. Wish the company would pump out a few PR’s. I’m still holding onto the fact that leadership informed us that their revenue is set to double in the second half of 2024 📈📈
1 · Reply
Slavage
Slavage Oct. 5 at 7:32 PM
$INCR I don't think owning is good idea. Right now. Isreal is in 1 war that isn't likely to harm this company again. But the other two sides of a long distance war... will likely point a few at this company's property... again. When the number matter. Ie time and military and economic value are of the most important factors for defense... What are the odds that this company will be hit? Be careful with your money...
0 · Reply
JesusWhale
JesusWhale Sep. 20 at 6:44 PM
$INCR bought more down here. Revenue is set to double in the second half of 2024, easy buy and hold.
1 · Reply
WhatsUpWhatsNot
WhatsUpWhatsNot Sep. 18 at 7:05 PM
$AAPL, $F, $INCR nice moves..of course no one follows $INCR
1 · Reply
JohnKeynes
JohnKeynes Sep. 18 at 5:14 PM
$INCR Buying opportunity under $2.
1 · Reply